Detection of abnormalities in B‐cell differentiation pattern is a useful tool to predict relapse in precursor‐B‐ALL

No abstract is available for this paper.

• Publication year

  1999

• Venue

  British Journal of Haematology

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2141.1999.01236.xPMID 10192428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

  1999cited by this paper
• Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.

  1998cited by this paper
• Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

  1998cited by this paper
• Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow

  1997influential reference
• Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

  1996cited by this paper
• Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia.

  1996cited by this paper
• Routine bone marrow exam during first remission of acute myeloid leukemia.

  1996cited by this paper
• Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance.

  1995cited by this paper
• Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.

  1995cited by this paper
• Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.

  1995cited by this paper
• Detection of residual leukemia with immunologic methods: technical developments and clinical implications.

  1994cited by this paper
• Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry.

  1994cited by this paper
• Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.

  1994cited by this paper
• The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia

  1993cited by this paper
• Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and review.

  1993influential reference
• Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.

  1992cited by this paper
• Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.

  1992cited by this paper
• Detection of minimal residual disease in acute lymphoblastic leukemia by flow cytometry with monoclonal antibodies

  1991cited by this paper
• The definition of remission in acute leukemia with immunologic techniques.

  1991cited by this paper
• Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.

  1991cited by this paper
• The immunologic detection of minimal residual disease in acute leukemia.

  1990cited by this paper
• Ontogeny of normal human B-cell and T-cell precursors and its relation to leukemogenesis.

  1990cited by this paper
• Increased light scattering resolution facilitates multidimensional flow cytometric analysis.

  1990cited by this paper
• Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.

  1990cited by this paper
• Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow.

  1988cited by this paper
• Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.

  1988cited by this paper
• Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development.

  1987cited by this paper
• The Acute leukemias : biologic, diagnostic, and therapeutic determinants

  1987cited by this paper
• Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia.

  1986cited by this paper
• Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens.

  1986cited by this paper
• Lineage heterogeneity in acute leukaemia: acute mixed-lineage leukaemia and lineage switch.

  1986cited by this paper
• Lineage switch in acute leukemia.

  1984cited by this paper

• The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia

  2024cites this paper
• Flow Cytometric MRD Assessment in Acute Lymphoblastic Leukemias

  2023cites this paper
• Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia

  2020cites this paper
• Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges

  2018cites this paper
• Minimal Residual Disease (MRD) Diagnostics: Methodology and Prognostic Significance

  2017cites this paper
• Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies.

  2015cites this paper
• The importance of immunophenotyping by flow cytometry in distinction between hematogones and B lymphoblasts

  2015cites this paper
• [Aberrant immunophenotypes in acute leukemia in a Buenos Aires' hospital population].

  2013cites this paper
• high clinical value has acute lymphoblastic leukemias: early immunophenotypic evaluation Minimal residual disease in adolescent (older than 14 years) and adult

  2013cites this paper
• Inmunofenotipos aberrantes en leucemias agudas en una población hospitalaria de Buenos Aires

  2013cites this paper
• 662 consecutive bone marrow specimens by 4-color flow cytometry Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in

  2012cites this paper
• Flow cytometry results at diagnosis and relapse in childhood acute lymphoblastic leukemia.

  2010cites this paper
• Simplified flow cytometric assay to detect minimal residual disease in childhood with acute lymphoblastic leukemia

  2008cites this paper
• [Distribution of antigenic aberration in the bone marrow of acute leukemia in complete remission].

  2008cites this paper
• The changing pattern of “smart” flow cytometry (S‐FC) to assist the cost‐effective diagnosis of HIV, tuberculosis, and leukemias in resource‐restricted conditions

  2008cites this paper
• Minimal Residual Disease Studies in Acute Lymphoblastic Leukemia

  2008influential citation
• Utilidad del inmunofenotipo en el diagnóstico y el seguimiento de la leucemia linfoblástica aguda del adulto

  2007cites this paper
• Minimal disease detection and confirmation in hematologic malignancies: combining cell sorting with clonality profiling.

  2006cites this paper
• Flow cytometric immunophenotyping of normal and malignant lymphocytes / Immunphänotypisierung normaler und maligner Lymphozyten mittels Durchflusszytometrie

  2006cites this paper
• Flow-cytometric immunophenotyping of normal and malignant lymphocytes

  2006cites this paper
• Immunophenotyping of acute leukaemias.

  2005cites this paper
• New Applications of Flow Cytometry in Cancer Diagnosis and Therapy

  2004cites this paper
• Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia.

  2004cites this paper
• Minimal residual disease studies in acute leukemia.

  2004cites this paper
• Minimal Residual Disease Studies by Flow Cytometry in Acute Leukemia

  2004cites this paper
• Adult acute lymphoblastic leukaemia.

  2004cites this paper
• Immunophenotyping of acute leukemias and myelodysplastic syndromes

  2004cites this paper
• Cancer Diagnostics

  2004cites this paper
• Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.

  2004cites this paper
• Immunophenotypic Analysis of Hematogones (B-Lymphocyte Precursors) and Neoplastic Lymphoblasts by 4-Color Flow Cytometry

  2004cites this paper
• Flow Cytometric Analysis of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

  2003cites this paper
• Investigation of Minimal Residual Disease in Acute Myeloid Leukemia by Immunophenotyping

  2003cites this paper
• Immunophenotypic analysis of myelodysplastic syndromes.

  2003cites this paper
• Immunologic monitoring in adults with acute lymphoblastic leukemia

  2003cites this paper
• Minimal residual disease monitoring by flow cytometry.

  2003cites this paper
• Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia

  2003cites this paper
• Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

  2003cites this paper
• Flow-Cytometry—Based Studies of Minimal Residual Disease in Children with Acute Lymphoblastic Leukemia

  2003cites this paper
• Immunophenotypic analysis of acute lymphocytic leukemia.

  2002cites this paper
• [Applicability of flow cytometry in the diagnosis and immunophenotyping follow-up of acute leukemias].

  2002cites this paper
• Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.

  2002cites this paper
• Clinical Observations, Interventions, and Therapeutic Trials

  2002cites this paper
• Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).

  2002cites this paper
• Multidimensional Flow Cytometry Immunophenotyping of Hematologic Malignancy

  2002cites this paper
• Club Español de Citología Hematológica: el linfoblasto en el contexto de la leucemia linfoblástica aguda

  2002cites this paper
• Aplicación de la citometría de flujo al diagnóstico y seguimiento inmunofenotípico de las leucemias agudas

  2002cites this paper
• BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

  2001cites this paper
• Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.

  2001cites this paper
• Flow cytometric analysis of hematologic neoplasia.

  2001cites this paper
• Clinical and biological significance of CD34 expression in acute leukemia.

  2001cites this paper
• Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features.

  2000cites this paper
• Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease.

  2000cites this paper
• Regenerating normal B‐cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

  2000cites this paper
• CD66 expression in acute leukaemia

  2000cites this paper
• Flow cytometric detection of B cell abnormal maturation in chronic myeloid leukemia

  2000cites this paper
• Minimal residual disease.

  1999cites this paper
• Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

  1999cites this paper